Ziftomenib

Ziftomenib (Komzifti) is a medication for adults with a type of blood cancer called acute myeloid leukemia (AML). It's prescribed for AML that has returned or hasn't responded to previous treatments, specifically when the cancer cells have a particular genetic change called an NPM1 mutation. This medicine works by targeting a specific process within the cancer cells, aiming to stop their abnormal growth and support the production of healthy blood cells. In this topic, you can learn about how Ziftomenib is used, its potential effects, and what to consider during treatment to help you understand your options and discuss them with your healthcare team.